Page last updated: 2024-11-05

3-methylfuran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Methylfuran is a heterocyclic organic compound with the formula C4H3CH3O. It is a colorless liquid with a pungent odor. 3-Methylfuran is a valuable building block for the synthesis of various pharmaceuticals, polymers, and fine chemicals. It is also a promising biofuel candidate due to its high energy density and low emissions. The compound is often synthesized through various methods, including the dehydration of 2-pentanol, the catalytic hydrogenation of furfural, and the reaction of furfural with methyl magnesium bromide. 3-Methylfuran has been extensively studied for its potential applications in various fields. Its properties, such as its high boiling point, good stability, and reactivity, make it a suitable candidate for fuel production. Research is ongoing to optimize the synthesis and utilization of 3-methylfuran as a renewable and sustainable energy source. The compound exhibits interesting reactivity and has been explored for various chemical transformations, including oxidation, reduction, and ring opening reactions. Its potential applications in organic synthesis and materials science are being investigated. 3-Methylfuran has also been studied for its biological activity. Some studies suggest potential antimicrobial and antifungal properties, although further research is needed to confirm these effects.'

3-methylfuran: RN given refers to cpd with specified locant for methyl group [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-methylfuran : A member of the class of furans that is furan in which the hydrogen at position 3 is replaced by a methyl group. It is a chemical that is produced in foods during food processing and preservation techniques that involve heat treatment such as cooking and pasteurization. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID13587
CHEBI ID172946
MeSH IDM0119038

Synonyms (35)

Synonym
CHEBI:172946
4-methylfuran
3-methylfurane
3-methyl-furan
nsc346905
nsc-346905
brn 0104217
nsc 346905
furan, 3-methyl-
inchi=1/c5h6o/c1-5-2-3-6-4-5/h2-4h,1h
3-methylfuran
930-27-8
M0939
A844425
AKOS005255084
5r72a0440n ,
5-17-01-00330 (beilstein handbook reference)
unii-5r72a0440n
GEO-01834
FT-0671790
FT-0616160
DTXSID10239228
mfcd00060134
3-methylfuran, aldrichcpr
W18310
3-methylfuran (stabilized with hq)
3-methylfuran 100 microg/ml in methanol
3-methylfuran (stabilised with hydroquinone)
BBL103814
STL557624
3-methyl furan
3-methylfuran-methyl-d3
Q21099678
GS-0656
EN300-88698

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"0 mg/kg bw/day in order to determine the dose range needed to establish a no observed adverse effect level and to better characterize nonneoplastic effects including those affecting hematology, clinical biochemistry, gross morphology, and histopathology."( A 28-day gavage toxicity study in Fischer 344 rats with 3-methylfuran.
Barker, M; Cherry, W; Cooke, GM; Gill, S; Kavanagh, M; Weld, M, 2015
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Aspergillus metaboliteAny fungal metabolite produced during a metabolic reaction in the mould, Aspergillus.
Penicillium metaboliteAny fungal metabolite produced during a metabolic reaction in Penicillium.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
furansCompounds containing at least one furan ring.
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (25.00)18.7374
1990's2 (10.00)18.2507
2000's3 (15.00)29.6817
2010's10 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.40 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies1 (5.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]